Castle Biosciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 83.7M | 87.0M | 83.0M | 86.2M | 88.0M | 86.3M | 85.8M | 87.0M |
| Cost of Goods Sold | 23.3M | 18.3M | 18.7M | 17.6M | 16.4M | 16.2M | 15.6M | 14.5M |
| Gross Profit | 60.4M | 68.7M | 64.3M | 68.6M | 71.6M | 70.1M | 70.2M | 72.5M |
| R&D Expenses | 14.4M | 13.5M | 13.0M | 12.8M | 12.6M | 11.7M | 12.3M | 14.1M |
| Operating Expenses | 78.8M | 72.5M | 71.1M | 72.8M | 99.5M | 66.1M | 65.1M | 67.5M |
| Operating Income | -18.4M | -3.8M | -6.8M | -4.3M | -27.9M | 4.0M | 5.1M | 5.0M |
| Other Income / Gains | 4.0M | 1.1M | 6.4M | 4.1M | 1.7M | 3.8M | 3.2M | 2.9M |
| Net Income | -14.5M | -2.3M | -501K | 4.5M | -25.8M | 9.6M | 2.3M | 8.9M |
| EPS (Diluted) | -0.49 | -0.08 | -0.02 | 0.16 | -0.90 | 0.34 | 0.082 | 0.32 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.722 | 0.79 | 0.775 | 0.795 | 0.814 | 0.813 | 0.818 | 0.833 |
| General And Administrative Expenses | 0 | 23.3M | 23.1M | 22.9M | 21.8M | 19.6M | 20.7M | 18.4M |
| Selling And Marketing Expenses | 0 | 33.4M | 32.8M | 35.1M | 36.8M | 30.4M | 29.8M | 32.7M |
| Selling General And Administrative Expenses | 64.9M | 56.7M | 55.9M | 58.1M | 58.6M | 50.0M | 50.5M | 51.1M |
| Other Expenses | -545K | 2.3M | 2.3M | 2.0M | 28.3M | 4.4M | 2.3M | 2.2M |
| Cost And Expenses | 102.1M | 90.8M | 89.8M | 90.4M | 115.9M | 82.3M | 80.7M | 82.0M |
| Interest Income | 2.5M | 2.9M | 2.8M | 2.9M | 3.1M | 3.4M | 3.4M | 3.1M |
| Interest Expense | 134K | 24K | 24K | 21K | 17K | 92K | 201K | 270K |
| Depreciation And Amortization | 3.9M | 3.8M | 5.6M | 3.4M | 29.8M | 5.8M | 3.5M | 3.3M |
| Ebitda | -14.4M | 1.1M | 5.2M | 3.3M | 3.5M | 13.7M | 12.0M | 11.5M |
| Ebitdaratio | -0.172 | 0.012 | 0.063 | 0.038 | 0.04 | 0.159 | 0.14 | 0.132 |
| Operating Income Ratio | -0.22 | -0.044 | -0.082 | -0.049 | -0.317 | 0.047 | 0.059 | 0.058 |
| Income Before Tax | -14.4M | -2.7M | -386K | -143K | -26.3M | 7.9M | 8.3M | 7.9M |
| Income Before Tax Ratio | -0.172 | -0.031 | -0.005 | -0.002 | -0.299 | 0.091 | 0.097 | 0.091 |
| Income Tax Expense | 109K | -382K | 115K | -4.7M | -423K | -1.7M | 6.0M | -1.0M |
| Net Income Ratio | -0.174 | -0.027 | -0.006 | 0.052 | -0.294 | 0.111 | 0.026 | 0.103 |
| Epsdiluted | -0.49 | -0.08 | -0.017 | 0.15 | -0.90 | 0.32 | 0.077 | 0.31 |
| Weighted Average Shs Out | 29.9M | 29.3M | 25.1M | 28.9M | 28.6M | 28.1M | 27.8M | 27.6M |
| Weighted Average Shs Out Dil | 29.9M | 29.3M | 29.1M | 29.5M | 28.6M | 30.2M | 29.4M | 28.7M |